“30 Under 30” in Healthcare

“When I saw that I had been named as a Forbes 30 Under 30, I was shocked,” he says. I’m just a kid from Vancouver trying to do some good in the world, so this will take a while to fully sink in. All I can say is that it is truly an honor to represent Vancouver and UBC on the international stage. Hopefully I can help pave the way and inspire the Forbes 30 under 30 recipients of the future.”

Mohit Sodhi, a UBC medical student, has been named one of Forbes’ top “30 Under 30” in Healthcare. Launched in 2011, the Forbes “30 Under 30” recognizes people under the age of 30 from a wide range of industries who are making a notable impact in their field. For the Healthcare category, the recipients include entrepreneurs and researchers who are taking on some of healthcare’s biggest challenges.

As a graduate from UBC’s Experimental Medicine Program, and under the supervision of Dr. Mahyar Etminan, Sodhi collaborates on research that examines rare adverse events of some of the most commonly prescribed medications. In one such study, he and his colleagues identified cardiac issues from fluoroquinolone that led to regulatory agencies revising their recommendations for its use. Other studies uncovered eye damage from erectile dysfunction drugs and serious gastrointestinal side effects from GLP-1 drugs like Ozempic.

Learn more about UBC medical student Mohit Sodhi named one of Forbes “30 Under 30” in Healthcare via UBC Faculty of Medicine.